FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults
Posted:
The Food and Drug Administration expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing its use for at-risk adults as young as 50.
Voice AI company SuperDial helps billing and provider organizations reclaim time and revenue by replacing hours of insurer calls with end-to-end AI agents.
The debt and equity series A round was led by SignalFire, with participation from Slow Ventures, Box…
According to recent survey data pending review and publication (Rousmaniere et al. 2025) yet widely circulated, 48.7 percent of 499 U.S. respondents reported using LLMs (large language models) for psychological support in the preceding year. The majority did this for anxiety,…
Attendees
Sponsors and Exhibitors
Contact us